Canada Proposes Amendments to Adverse Drug Reaction Reporting

October 2009

Teresa A. Reguly

Tags:

Advertising and Marketing Food and Drug Regulatory Intellectual Property Life Sciences Pharmaceuticals

Related Expertise

Related Insights

Canada’s new biomanufacturing and life sciences investment strategy
“This Court does not sign blank cheques”: Federal Court of Appeal reverses Canada’s Patented Medicine Prices Review Board, restricting Board’s price control mandate
Important changes ahead for regulation of supplemented foods and labelling of natural health products
Déjà vu: Another delay in implementation of Canada’s PMPRB Regulations
Get your daily dose! Regulatory framework for supplemented foods and updated labelling for natural health products coming to Canada

Back